These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 18832913)
1. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
3. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule. Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865 [TBL] [Abstract][Full Text] [Related]
4. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis. Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release. Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754 [TBL] [Abstract][Full Text] [Related]
8. Two novel mutations in the fibrinogen γ nodule. Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
10. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Haverkate F; Samama M Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487 [TBL] [Abstract][Full Text] [Related]
11. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen. Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization. Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648 [TBL] [Abstract][Full Text] [Related]
14. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain]. Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582 [TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725 [TBL] [Abstract][Full Text] [Related]
17. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain. Mimuro J; Muramatsu S; Maekawa H; Sakata Y; Kaneko M; Yoshitake S; Okuma M; Ito Y; Takeda Y; Matsuda M Int J Hematol; 1992 Oct; 56(2):129-34. PubMed ID: 1421174 [TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA). Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498 [TBL] [Abstract][Full Text] [Related]
19. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families. Meyer M; Bergmann F; Brennan SO Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083 [TBL] [Abstract][Full Text] [Related]
20. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations. Castaman G; Giacomelli SH; Duga S; Rodeghiero F Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984 [No Abstract] [Full Text] [Related] [Next] [New Search]